{"id":"W2229481660","doi":"10.1097/jto.0000000000000588","title":"Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology; Genentech; AstraZeneca; Celgene; Merck KGaA; Sanofi; Eli Lilly and Company","keywords":"Cabazitaxel; Topotecan; Taxane; Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Lung cancer; Confidence interval; Surgery; Cancer; Prostate cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006988661,0.00035229,0.001667971,0.0003145615,0.0003079456,0.0007244798,0.0004277687,0.0006105502,0.001281296],"category_scores_gemma":[0.001912015,0.0001877896,0.001333926,0.000475017,0.0003452909,0.0006122067,0.0002058042,0.001422498,0.0001366721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147286,"about_ca_system_score_gemma":0.00118952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004325641,"about_ca_topic_score_gemma":0.01396939,"domain_scores_codex":[0.9996513,0.0001316525,0.00002675066,0.00004521251,0.00003836525,0.0001067948],"domain_scores_gemma":[0.9992563,0.0003322415,0.0001155956,0.00002915193,0.00002689469,0.000239812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7864582,0.002324386,0.09152871,0.0009429215,0.002971504,0.001043696,0.0003337732,0.00240828,0.006795011,0.0002862857,0.001726451,0.1031807],"study_design_scores_gemma":[0.128036,0.2273185,0.6125687,0.0003393661,0.01090743,0.002440288,0.0007235027,0.005249826,0.004518383,0.0007118512,0.007065488,0.0001206556],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932566,0.005309159,0.00004117166,0.0002378183,0.00009980971,0.00004036806,0.0001622939,0.000007312155,0.0008455015],"genre_scores_gemma":[0.9974347,0.001842095,0.00006476135,0.0001356005,0.00009057103,0.00001597614,0.0001601545,0.000002511362,0.000253639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004325641,"threshold_uncertainty_score":0.008600891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0301059198192701,"score_gpt":0.4078467590959927,"score_spread":0.3777408392767226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}